<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00848393</url>
  </required_header>
  <id_info>
    <org_study_id>IRB08-00029</org_study_id>
    <secondary_id>101911</secondary_id>
    <nct_id>NCT00848393</nct_id>
  </id_info>
  <brief_title>Measures to Lower the Stress Response in Pediatric Cardiac Surgery</brief_title>
  <official_title>Stress Response in Children Undergoing Cardiac Surgery: a Prospective Randomized Comparison Between Low Dose Fentanyl (LDF), Low Dose Fentanyl Plus Dexmedetomidine (LDF + Dex) and High Dose Fentanyl (HDF).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nationwide Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nationwide Children's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiac surgery induces a measurable stress response in patients which leads to increased
      morbidity and mortality post-operatively. Through clinical observation, anesthesiologists
      have determined that varying the combinations of anesthesia drugs used during surgery and
      just after reduces the stress response, and by extension, morbidity and mortality. However,
      only a few studies have explored this phenomenon scientifically.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, we aim to demonstrate comparatively that use of dexmedetomidine in addition to
      low dose narcotics reduces the stress response in cardiac surgical patients and results in
      less morbidity and mortality. Additionally, dexmedetomidine (Dex) should facilitate safe
      early extubation in pediatric cardiac patients, which results in decreased ventilator
      associated co-morbidities. Patients will be randomly assigned to three groups; one group will
      receive low dose fentanyl (LDF), one will receive low dose fentanyl with dexmedetomidine (LDF
      + Dex), and one will receive high dose fentanyl (HDF). Blood samples will be collected
      post-induction, post-sternotomy, after going on cardiopulmonary bypass, at the completion of
      surgery, and post-operatively to determine the patients' stress hormone levels. The patients
      will receive standard post-operative care, and clinical data collected as part of this care
      will be used to determine the incidence of morbidity and mortality. The results of the blood
      tests will be correlated with the incidence of morbidity and mortality to demonstrate the
      relative effectiveness of the different anesthesia methods.

      Blood samples will be analyzed for the presence of the stress hormones cortisol, epinephrine,
      norepinephrine, adrenocorticotropic hormone (ACTH), Interleukin 8 (IL-8), TNF-alpha (Tumor
      Necrosis Factor), and nitrated albumin. Arterial blood gas, glucose and lactate levels, heart
      rate, blood pressure, use of vasoactive support, length of ventilator use, post-operative
      mortality, post-operative morbidity, length of Intensive Care Unit (ICU) stay, and length of
      hospital stay will be recorded.

      Children previously enrolled in the surgery study will complete assessments of their
      cognitive ability, developmental status, and emotional and behavioral adjustment. For the
      neuro-developmental outcome follow up, Children's cognitive ability will be assessed using
      the Stanford-Binet Intelligence Scales, 5th Edition (SB5). The SB5 is a widely-used measure
      of intellectual functioning that is normed for ages 2 and up. The test takes 30-50 minutes to
      administer to young children, and provides an overall Intelligence Quotient (IQ) score, as
      well as scores for five primary factors of cognitive ability: Fluid Reasoning, Knowledge,
      Quantitative Reasoning, Visual-Spatial Processing; and Working Memory. The SB5 has
      demonstrated excellent reliability and validity.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ACTH and Cytokine Levels</measure>
    <time_frame>Blood draws to measure cytokines levels within one hour of draw: after induction; after sternotomy; after starting cardiopulmonary bypass; at the end of the procedure; and 24 hours after the procedure.</time_frame>
    <description>N = 48 n = 16 (LDF); n = 17 (HDF); n = 15 (LDF + Dex) ACTH assayed by enzyme-linked immunosorbent assay (ELISA); Cytokine levels in plasma were measured using the Immulite automated chemiluminometer. Measured cytokines include interleukin (IL)-6, IL-8, IL-10, and tumor necrosis factor-Î±.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparisons Between Groups for Narcotic and/or Dexmedetomidine Intervention Influence on Length of CTICU Stay.</measure>
    <time_frame>Hospital admission to discharge from CTICU (average of 2-4 days)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparisons Between Groups for Narcotic and/or Dexmedetomidine Intervention Influence on Time on Ventilator.</measure>
    <time_frame>Time of intubation to extubation (variable)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Stanford-Binet Intelligence Scales</measure>
    <time_frame>1-4 yrs. post-surgery</time_frame>
    <description>The Stanford-Binet test evaluates the overall IQ score from the assessment of cognitive ability. The test consists of 15 subtests, grouped into the four area scores. Six subtests are administered to all age levels. The subtests are: Vocabulary, Comprehension, Pattern Analysis, Quantitative, Bead Memory, and Memory for Sentences. Number of tests administered and test difficulty are based on the test taker's age and performance on subtest measuring word knowledge. The word knowledge subtest is given to all test takers and is the first subtest administered. A score of 100 is in the normal or average range. Higher scores suggest a higher level of functioning related to each category. (University of Cincinnati, 2003) Raw scores for each subtest within the overall test are converted to scaled scores using a table within each test manual to look up equivalents. Scaled scores are then converted to standard scores (range=50-150).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stress Hormone Levels</measure>
    <time_frame>Blood draws to measure stress hormone levels within one hour of draw: after induction; after sternotomy; after starting cardiopulmonary bypass; at the end of the procedure; and 24 hours after the procedure.</time_frame>
    <description>Cortisol, epinephrine, and norepinephrine assayed by enzyme-linked immunosorbent assay (ELISA).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stanford-Binet Cognitive Ability</measure>
    <time_frame>1-4 yrs post-surgery</time_frame>
    <description>The Stanford-Binet Intelligence Scale is now in its fifth edition (SB5) and was released in 2003. It is a cognitive ability and intelligence test that is used to diagnose developmental or intellectual deficiencies in young children. The test measures five weighted factors and consists of both verbal and nonverbal subtests. The five factors being tested are knowledge, quantitative reasoning, visual-spatial processing, working memory, and fluid reasoning. Raw scores for each subtest within the overall test are converted to scaled scores using a table within each test manual to look up equivalents. Scaled scores are then converted to standard scores (range=50-150). Higher scores suggest a higher level of functioning related to each category.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ABAS-II</measure>
    <time_frame>1-4 yrs post-surgery</time_frame>
    <description>The ABAS-II is designed to evaluate whether an individual displays various functional skills necessary for daily living without the assistance of others. Thus, this instrument focuses on independent behaviors and measures what an individual actually does, in addition to measuring what he or she may be able to do. In addition, the ABAS-II focuses on behaviors an individual displays on his or her own, without assistance from others. The Parent/Primary Caregiver Form is a comprehensive, diagnostic measure of the adaptive skills that have primary relevance for the functioning of infants, toddlers, and preschoolers in the home and other settings, and can be completed by parents or other primary care providers. Each composite or domain score is determined by summing the appropriate scaled scores and then determining its equivalent composite or domain score by looking it up in a table located in the manual.The range for all scores is 50-150, with a higher score equaling a better outcome.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">52</enrollment>
  <condition>Tetralogy of Fallot (TOF)</condition>
  <condition>Ventricular Septal Defects (VSD)</condition>
  <condition>Atrioventricular Septal Defects (AVSD)</condition>
  <arm_group>
    <arm_group_label>Fentanyl (High Dose)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This arm will receive a total of 25 mcg/kg of Fentanyl (High Dose) in two divided doses. First half-dose given at induction and second half-dose given before incision.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fentanyl (Low Dose)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This arm will receive a total of 10 mcg/kg of Fentanyl (Low Dose). First half-dose will be given at induction and second half -dose given before incision.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fentanyl (Low Dose) + Dexmedetomidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This arm will receive10 mcg/kg of Fentanyl (Low Dose) -2 divided doses. Dexmedetomidine (Dex) loading dose-1 mcg/kg over 10 min, then Dex infusion at 0.5mcg/kg/hr.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl (High Dose)</intervention_name>
    <description>Fentanyl (High Dose) 25 mcg/kg in two divided doses. Half-dose will be given at induction and the second half-dose given prior to incision.</description>
    <arm_group_label>Fentanyl (High Dose)</arm_group_label>
    <other_name>Fentanyl citrate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl (Low Dose)</intervention_name>
    <description>Fentanyl (Low Dose) 10 mcg/kg in two divided doses. Half-dose will be given at induction and the second half-dose given prior to incision.</description>
    <arm_group_label>Fentanyl (Low Dose)</arm_group_label>
    <other_name>Fentanyl citrate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl (Low Dose) + Dexmedetomidine</intervention_name>
    <description>Fentanyl (Low Dose) + Dexmedetomidine. Dexmedetomidine at 1mcg/kg loading dose over 10 minutes, followed by an infusion at a rate of 0.5mcg/kg/hr. In addition, this group will receive a total of 10 mcg/kg Fentanyl (Low Dose). Half the dose will be given at induction and the second half before incision.</description>
    <arm_group_label>Fentanyl (Low Dose) + Dexmedetomidine</arm_group_label>
    <other_name>Fentanyl citrate + Precedex for dexmedetomidine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Childrens with the diagnosis of tetralogy of fallot, ventricular septal defect and
             atrioventricular septal defect who are under one year of age.

        Exclusion Criteria:

          -  Patients who are having reoperation.

          -  Patients with comorbidities, such as heart failure.

          -  Patients receiving digoxin preoperatively.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>3 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aymen N Naguib, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nationwide Children's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nationwide Children's Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Mukhtar AM, Obayah EM, Hassona AM. The use of dexmedetomidine in pediatric cardiac surgery. Anesth Analg. 2006 Jul;103(1):52-6, table of contents.</citation>
    <PMID>16790625</PMID>
  </reference>
  <reference>
    <citation>Mellon RD, Simone AF, Rappaport BA. Use of anesthetic agents in neonates and young children. Anesth Analg. 2007 Mar;104(3):509-20. Review.</citation>
    <PMID>17312200</PMID>
  </reference>
  <reference>
    <citation>Anand KJ, Hickey PR. Halothane-morphine compared with high-dose sufentanil for anesthesia and postoperative analgesia in neonatal cardiac surgery. N Engl J Med. 1992 Jan 2;326(1):1-9.</citation>
    <PMID>1530752</PMID>
  </reference>
  <reference>
    <citation>Anand KJ, Hansen DD, Hickey PR. Hormonal-metabolic stress responses in neonates undergoing cardiac surgery. Anesthesiology. 1990 Oct;73(4):661-70.</citation>
    <PMID>2221435</PMID>
  </reference>
  <reference>
    <citation>Kapoor MC, Ramachandran TR. Inflammatory response to cardiac surgery and strategies to overcome it. Ann Card Anaesth. 2004 Jul;7(2):113-28.</citation>
    <PMID>17827544</PMID>
  </reference>
  <reference>
    <citation>Gruber EM, Laussen PC, Casta A, Zimmerman AA, Zurakowski D, Reid R, Odegard KC, Chakravorti S, Davis PJ, McGowan FX Jr, Hickey PR, Hansen DD. Stress response in infants undergoing cardiac surgery: a randomized study of fentanyl bolus, fentanyl infusion, and fentanyl-midazolam infusion. Anesth Analg. 2001 Apr;92(4):882-90.</citation>
    <PMID>11273919</PMID>
  </reference>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>February 19, 2009</study_first_submitted>
  <study_first_submitted_qc>February 19, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 20, 2009</study_first_posted>
  <results_first_submitted>January 26, 2016</results_first_submitted>
  <results_first_submitted_qc>July 2, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">July 27, 2018</results_first_posted>
  <last_update_submitted>July 2, 2018</last_update_submitted>
  <last_update_submitted_qc>July 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nationwide Children's Hospital</investigator_affiliation>
    <investigator_full_name>Aymen N Naguib</investigator_full_name>
    <investigator_title>Director of Pediatric Cardiothoracic Anesthesia</investigator_title>
  </responsible_party>
  <keyword>pediatric cardiac surgery</keyword>
  <keyword>stress response</keyword>
  <keyword>early extubation</keyword>
  <keyword>Dexmedetomidine</keyword>
  <keyword>TOF</keyword>
  <keyword>VSD</keyword>
  <keyword>AVSD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Septal Defects</mesh_term>
    <mesh_term>Tetralogy of Fallot</mesh_term>
    <mesh_term>Heart Septal Defects, Ventricular</mesh_term>
    <mesh_term>Endocardial Cushion Defects</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Citric Acid</mesh_term>
    <mesh_term>Sodium Citrate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>A total of 51 study subjects completed the study.</recruitment_details>
      <pre_assignment_details>Total number of subjects recruited was 52 patients (one enrollee withdrew prior to any study-related procedures) resulting in a total number of subjects participating of 51. The enrollee was withdrawn from the study after signing the consent and prior to enrolling to one of the arms of the study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Fentanyl (High Dose)</title>
          <description>Patients in this arm will receive a total of 25 mcg/kg of Fentanyl (High Dose) in two divided doses. first half will be given at induction and the second half will be given before incision.
Fentanyl (High Dose): 25 mcg/kg in two divided doses. half the dose will be given at induction and the second half will be given prior to incision.</description>
        </group>
        <group group_id="P2">
          <title>Fentanyl (Low Dose)</title>
          <description>Patients in this arm will receive a total of 10 mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half will be given before incision
Fentanyl (Low Dose): patients will receive a total of 10 mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half before incision.</description>
        </group>
        <group group_id="P3">
          <title>Fentanyl (Low Dose) + Dexmedetomidine</title>
          <description>Patients in this arm will receive a total of 10 mcg/kg of Fentanyl (Low Dose) in two divided doses and Dexmedetomidine at a loading dose of 1 mcg/kg over 10 minutes and then an infusion of Dexmedetomidine at 0.5mcg/kg/hr.
Fentanyl (Low Dose) + Dexmedetomidine: Dexmedetomidine at 1 mcg/kg loading dose over 10 minutes, followed by an infusion at a rate of 0.5 mcg/kg/hr. In addition, this group will receive a total of 10 mcg/kg Fentanyl (Low Dose). Half the dose will be given at induction and the second half before incision.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="16"/>
                <participants group_id="P3" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="16"/>
                <participants group_id="P3" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>surgical complications unrelated to stud</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Fentanyl (High Dose)</title>
          <description>patients in this arm will receive a total of 25 mcg/kg of Fentanyl (High Dose) in two divided doses. first half will be given at induction and the second half will be given before incision.
Fentanyl (High Dose): 25 mcg/kg in two divided doses. half the dose will be given at induction and the second half will be given prior to incision.</description>
        </group>
        <group group_id="B2">
          <title>Fentanyl (Low Dose)</title>
          <description>patients in this group will receive a total of 10mcg/kg of fentanyl. half the dose will be given at induction and the second half will be given before incision
Fentanyl (Low Dose): patients will receive a total of 10mcg/kg of fentanyl. half the dose will be given at induction and the second half before incision.</description>
        </group>
        <group group_id="B3">
          <title>Fentanyl (Low Dose) + Dexmedetomidine</title>
          <description>patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose) in two divided doses and Dexmedetomidine at a loading dose of 1mcg/kg over 10 minutes and then an infusion of Dexmedetomidine at 0.5mcg/kg/hr.
Fentanyl (Low Dose) + Dexmedetomidine: Dexmedetomidine at 1mcg/kg loading dose over 10 minutes, followed by an infusion at a rate of 0.5mcg/kg/hr. In addition, this group will receive a total of 10 mcg/kg Fentanyl (Low Dose). Half the dose will be given at induction and the second half before incision.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="17"/>
            <count group_id="B2" value="16"/>
            <count group_id="B3" value="15"/>
            <count group_id="B4" value="48"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="48"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>months</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4" lower_limit="1" upper_limit="35"/>
                    <measurement group_id="B2" value="4" lower_limit="3" upper_limit="7"/>
                    <measurement group_id="B3" value="5" lower_limit="2" upper_limit="21"/>
                    <measurement group_id="B4" value="4" lower_limit="1" upper_limit="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>ACTH and Cytokine Levels</title>
        <description>N = 48 n = 16 (LDF); n = 17 (HDF); n = 15 (LDF + Dex) ACTH assayed by enzyme-linked immunosorbent assay (ELISA); Cytokine levels in plasma were measured using the Immulite automated chemiluminometer. Measured cytokines include interleukin (IL)-6, IL-8, IL-10, and tumor necrosis factor-Î±.</description>
        <time_frame>Blood draws to measure cytokines levels within one hour of draw: after induction; after sternotomy; after starting cardiopulmonary bypass; at the end of the procedure; and 24 hours after the procedure.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fentanyl (High Dose)</title>
            <description>patients in this arm will receive a total of 25 mcg/kg of Fentanyl (High Dose) in two divided doses. first half will be given at induction and the second half will be given before incision.
Fentanyl (High Dose): 25 mcg/kg in two divided doses. half the dose will be given at induction and the second half will be given prior to incision.</description>
          </group>
          <group group_id="O2">
            <title>Fentanyl (Low Dose)</title>
            <description>patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half will be given before incision
Fentanyl (Low Dose): patients will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half before incision.</description>
          </group>
          <group group_id="O3">
            <title>Fentanyl (Low Dose) + Dexmedetomidine</title>
            <description>patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose) in two divided doses and Dexmedetomidine at a loading dose of 1mcg/kg over 10 minutes and then an infusion of Dexmedetomidine at 0.5mcg/kg/hr.
Fentanyl (Low Dose) + Dexmedetomidine: Dexmedetomidine at 1mcg/kg loading dose over 10 minutes, followed by an infusion at a rate of 0.5mcg/kg/hr.in addition this group will receive a total of 10 mcg/kg Fentanyl (Low Dose). Half the dose will be given at induction and the second half before incision.</description>
          </group>
        </group_list>
        <measure>
          <title>ACTH and Cytokine Levels</title>
          <description>N = 48 n = 16 (LDF); n = 17 (HDF); n = 15 (LDF + Dex) ACTH assayed by enzyme-linked immunosorbent assay (ELISA); Cytokine levels in plasma were measured using the Immulite automated chemiluminometer. Measured cytokines include interleukin (IL)-6, IL-8, IL-10, and tumor necrosis factor-Î±.</description>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="16"/>
                <count group_id="O3" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline ACTH (pg/mL)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="116.9" spread="117.0"/>
                    <measurement group_id="O2" value="182.7" spread="111.3"/>
                    <measurement group_id="O3" value="135.3" spread="129.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Sternotomy ACTH (pg/mL)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.5" spread="39.7"/>
                    <measurement group_id="O2" value="86.2" spread="76.5"/>
                    <measurement group_id="O3" value="106.9" spread="153.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Bypass ACTH (pg/mL)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.2" spread="61.2"/>
                    <measurement group_id="O2" value="172.7" spread="121.8"/>
                    <measurement group_id="O3" value="191.6" spread="220.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>End-Of-Surgery ACTH (pg/mL)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.4" spread="77.9"/>
                    <measurement group_id="O2" value="155.0" spread="107.5"/>
                    <measurement group_id="O3" value="154.1" spread="166.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hour Post-Surgery ACTH (pg/mL)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.7" spread="7.4"/>
                    <measurement group_id="O2" value="53.2" spread="24.3"/>
                    <measurement group_id="O3" value="22.4" spread="130.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline TNF-alpha (pg/mL)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.70077" spread="16.401"/>
                    <measurement group_id="O2" value="25.294" spread="31.22396"/>
                    <measurement group_id="O3" value="8.018182" spread="10.68364"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Sternotomy TNF-alpha (pg/mL)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.51846" spread="33.64902"/>
                    <measurement group_id="O2" value="24.497" spread="33.8474"/>
                    <measurement group_id="O3" value="17.88636" spread="16.96651"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Bypass TNF-alpha (pg/mL)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.30615" spread="23.03753"/>
                    <measurement group_id="O2" value="25.787" spread="29.267"/>
                    <measurement group_id="O3" value="20.34364" spread="14.03041"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>End-Of-Surgery TNF-alpha (pg/mL)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.87077" spread="17.18903"/>
                    <measurement group_id="O2" value="24.857" spread="18.82328"/>
                    <measurement group_id="O3" value="23.06091" spread="18.8737"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hour Post-Surgery TNF-alpha (pg/mL)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.79" spread="30.8563"/>
                    <measurement group_id="O2" value="11.954" spread="17.23623"/>
                    <measurement group_id="O3" value="21.13909" spread="19.00043"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline IL-6 (pg/mL)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.637058824" spread="4.356124661"/>
                    <measurement group_id="O2" value="4.757142857" spread="2.178819118"/>
                    <measurement group_id="O3" value="5.542857143" spread="3.455366904"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Sternotomy IL-6 (pg/mL)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.402353" spread="3.623996"/>
                    <measurement group_id="O2" value="12.17333" spread="28.79942"/>
                    <measurement group_id="O3" value="6.241333" spread="4.0798"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Bypass IL-6 (pg/mL)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.098824" spread="3.10355"/>
                    <measurement group_id="O2" value="5.509375" spread="3.93354"/>
                    <measurement group_id="O3" value="5.040667" spread="2.583747"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>End-Of-Surgery IL-6 (pg/mL)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.48571" spread="11.00962"/>
                    <measurement group_id="O2" value="22.47333" spread="12.59657"/>
                    <measurement group_id="O3" value="20.79231" spread="12.55537"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hour Post-Surgery IL-6 (pg/mL)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="126.0813" spread="141.7456"/>
                    <measurement group_id="O2" value="117.975" spread="95.86805"/>
                    <measurement group_id="O3" value="142.1571" spread="129.4279"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline IL-8 (pg/mL)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.12353" spread="24.88048"/>
                    <measurement group_id="O2" value="10.44286" spread="1.839195"/>
                    <measurement group_id="O3" value="10.25714" spread="1.336306"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Sternotomy IL-8 (pg/mL)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.77647" spread="42.23163"/>
                    <measurement group_id="O2" value="10.66667" spread="2.941736"/>
                    <measurement group_id="O3" value="10.86667" spread="1.980861"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Bypass IL-8 (pg/mL)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.770588" spread="2.389499"/>
                    <measurement group_id="O2" value="10.13125" spread="2.15769"/>
                    <measurement group_id="O3" value="9.673333" spread="1.182894"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>End-Of-Surgery IL-8 (pg/mL)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.1" spread="17.28596"/>
                    <measurement group_id="O2" value="33.12667" spread="25.1446"/>
                    <measurement group_id="O3" value="37.22143" spread="43.66227"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hour Post-Surgery IL-8 (pg/mL)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.07143" spread="69.39429"/>
                    <measurement group_id="O2" value="47.25" spread="99.4908"/>
                    <measurement group_id="O3" value="24.27143" spread="14.72541"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline IL-10 (pg/mL)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.82353" spread="1.952412"/>
                    <measurement group_id="O2" value="9.9" spread="0.00000"/>
                    <measurement group_id="O3" value="12.76429" spread="9.373252"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Sternotomy IL-10 (pg/mL)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.911765" spread="2.749291"/>
                    <measurement group_id="O2" value="9.9" spread="0.00000"/>
                    <measurement group_id="O3" value="14.10667" spread="13.63863"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Bypass IL-10 (pg/mL)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.488235" spread="1.872793"/>
                    <measurement group_id="O2" value="9.9" spread="2.581989"/>
                    <measurement group_id="O3" value="12.30667" spread="10.78136"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>End-Of-Surgery IL-10 (pg/mL)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="345.4412" spread="445.7443"/>
                    <measurement group_id="O2" value="325.55" spread="262.3603"/>
                    <measurement group_id="O3" value="569.2714" spread="858.2538"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hour Post-Surgery IL-10 (pg/mL)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.80667" spread="1.907304"/>
                    <measurement group_id="O2" value="14.80833" spread="10.65888"/>
                    <measurement group_id="O3" value="9.692857" spread="0.775058"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Comparisons Between Groups for Narcotic and/or Dexmedetomidine Intervention Influence on Length of CTICU Stay.</title>
        <time_frame>Hospital admission to discharge from CTICU (average of 2-4 days)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fentanyl (High Dose)</title>
            <description>patients in this arm will receive a total of 25 mcg/kg of Fentanyl (High Dose) in two divided doses. first half will be given at induction and the second half will be given before incision.
Fentanyl (High Dose): 25 mcg/kg in two divided doses. half the dose will be given at induction and the second half will be given prior to incision.</description>
          </group>
          <group group_id="O2">
            <title>Fentanyl (Low Dose)</title>
            <description>patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half will be given before incision
Fentanyl (Low Dose): patients will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half before incision.</description>
          </group>
          <group group_id="O3">
            <title>Fentanyl (Low Dose) + Dexmedetomidine</title>
            <description>patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose) in two divided doses and Dexmedetomidine at a loading dose of 1mcg/kg over 10 minutes and then an infusion of Dexmedetomidine at 0.5mcg/kg/hr.
Fentanyl (Low Dose) + Dexmedetomidine: Dexmedetomidine at 1mcg/kg loading dose over 10 minutes, followed by an infusion at a rate of 0.5mcg/kg/hr. In addition, this group will receive a total of 10 mcg/kg Fentanyl (Low Dose). Half the dose will be given at induction and the second half before incision.</description>
          </group>
        </group_list>
        <measure>
          <title>Comparisons Between Groups for Narcotic and/or Dexmedetomidine Intervention Influence on Length of CTICU Stay.</title>
          <units>Days</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="16"/>
                <count group_id="O3" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="1" upper_limit="8"/>
                    <measurement group_id="O2" value="1" lower_limit="1" upper_limit="4"/>
                    <measurement group_id="O3" value="2" lower_limit="1" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Comparisons Between Groups for Narcotic and/or Dexmedetomidine Intervention Influence on Time on Ventilator.</title>
        <time_frame>Time of intubation to extubation (variable)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fentanyl (High Dose)</title>
            <description>patients in this arm will receive a total of 25 mcg/kg of Fentanyl (High Dose) in two divided doses. first half will be given at induction and the second half will be given before incision.
Fentanyl (High Dose): 25 mcg/kg in two divided doses. half the dose will be given at induction and the second half will be given prior to incision.</description>
          </group>
          <group group_id="O2">
            <title>Fentanyl (Low Dose)</title>
            <description>patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half will be given before incision
Fentanyl (Low Dose): patients will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half before incision.</description>
          </group>
          <group group_id="O3">
            <title>Fentanyl (Low Dose) + Dexmedetomidine</title>
            <description>patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose) in two divided doses and Dexmedetomidine at a loading dose of 1mcg/kg over 10 minutes and then an infusion of Dexmedetomidine at 0.5mcg/kg/hr.
Fentanyl (Low Dose) + Dexmedetomidine: Dexmedetomidine at 1mcg/kg loading dose over 10 minutes, followed by an infusion at a rate of 0.5mcg/kg/hr. In addition, this group will receive a total of 10 mcg/kg Fentanyl (Low Dose). Half the dose will be given at induction and the second half before incision.</description>
          </group>
        </group_list>
        <measure>
          <title>Comparisons Between Groups for Narcotic and/or Dexmedetomidine Intervention Influence on Time on Ventilator.</title>
          <units>Hours</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="16"/>
                <count group_id="O3" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.75" lower_limit="0" upper_limit="27.32"/>
                    <measurement group_id="O2" value="3.79" lower_limit="0" upper_limit="16"/>
                    <measurement group_id="O3" value="2.4" lower_limit="0" upper_limit="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Stanford-Binet Intelligence Scales</title>
        <description>The Stanford-Binet test evaluates the overall IQ score from the assessment of cognitive ability. The test consists of 15 subtests, grouped into the four area scores. Six subtests are administered to all age levels. The subtests are: Vocabulary, Comprehension, Pattern Analysis, Quantitative, Bead Memory, and Memory for Sentences. Number of tests administered and test difficulty are based on the test taker's age and performance on subtest measuring word knowledge. The word knowledge subtest is given to all test takers and is the first subtest administered. A score of 100 is in the normal or average range. Higher scores suggest a higher level of functioning related to each category. (University of Cincinnati, 2003) Raw scores for each subtest within the overall test are converted to scaled scores using a table within each test manual to look up equivalents. Scaled scores are then converted to standard scores (range=50-150).</description>
        <time_frame>1-4 yrs. post-surgery</time_frame>
        <population>Six patients underwent their surgical repair after 1 y of age and were excluded from the follow-up neurodevelopmental testing post-surgery. 2 patients were deceased, 11 families refused to participate, 8 patients could not be reached due to relocation to other states or outside the country leaving a total of 21 patients.</population>
        <group_list>
          <group group_id="O1">
            <title>Fentanyl (High Dose)</title>
            <description>patients in this arm will receive a total of 25 mcg/kg of Fentanyl (High Dose) in two divided doses. first half will be given at induction and the second half will be given before incision.
Fentanyl (High Dose): 25 mcg/kg in two divided doses. half the dose will be given at induction and the second half will be given prior to incision.</description>
          </group>
          <group group_id="O2">
            <title>Fentanyl (Low Dose)</title>
            <description>patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half will be given before incision
Fentanyl (Low Dose): patients will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half before incision.</description>
          </group>
          <group group_id="O3">
            <title>Fentanyl (Low Dose) + Dexmedetomidine</title>
            <description>patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose) in two divided doses and Dexmedetomidine at a loading dose of 1mcg/kg over 10 minutes and then an infusion of Dexmedetomidine at 0.5mcg/kg/hr.
Fentanyl (Low Dose) + Dexmedetomidine: Dexmedetomidine at 1mcg/kg loading dose over 10 minutes, followed by an infusion at a rate of 0.5mcg/kg/hr. In addition, this group will receive a total of 10 mcg/kg Fentanyl (Low Dose). Half the dose will be given at induction and the second half before incision.</description>
          </group>
        </group_list>
        <measure>
          <title>Stanford-Binet Intelligence Scales</title>
          <description>The Stanford-Binet test evaluates the overall IQ score from the assessment of cognitive ability. The test consists of 15 subtests, grouped into the four area scores. Six subtests are administered to all age levels. The subtests are: Vocabulary, Comprehension, Pattern Analysis, Quantitative, Bead Memory, and Memory for Sentences. Number of tests administered and test difficulty are based on the test taker's age and performance on subtest measuring word knowledge. The word knowledge subtest is given to all test takers and is the first subtest administered. A score of 100 is in the normal or average range. Higher scores suggest a higher level of functioning related to each category. (University of Cincinnati, 2003) Raw scores for each subtest within the overall test are converted to scaled scores using a table within each test manual to look up equivalents. Scaled scores are then converted to standard scores (range=50-150).</description>
          <population>Six patients underwent their surgical repair after 1 y of age and were excluded from the follow-up neurodevelopmental testing post-surgery. 2 patients were deceased, 11 families refused to participate, 8 patients could not be reached due to relocation to other states or outside the country leaving a total of 21 patients.</population>
          <units>IQ</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Nonverbal IQ composite score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92" spread="19"/>
                    <measurement group_id="O2" value="98" spread="15"/>
                    <measurement group_id="O3" value="89" spread="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Verbal IQ composite score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93" spread="26"/>
                    <measurement group_id="O2" value="91" spread="17"/>
                    <measurement group_id="O3" value="80" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Full-scale IQ composite score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93" spread="24"/>
                    <measurement group_id="O2" value="94" spread="15"/>
                    <measurement group_id="O3" value="83" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Stress Hormone Levels</title>
        <description>Cortisol, epinephrine, and norepinephrine assayed by enzyme-linked immunosorbent assay (ELISA).</description>
        <time_frame>Blood draws to measure stress hormone levels within one hour of draw: after induction; after sternotomy; after starting cardiopulmonary bypass; at the end of the procedure; and 24 hours after the procedure.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fentanyl (High Dose)</title>
            <description>This arm will receive a total of 25 mcg/kg of Fentanyl (High Dose) in two divided doses. First half-dose given at induction and second half-dose given before incision.
Fentanyl (High Dose): Fentanyl (High Dose) 25 mcg/kg in two divided doses. Half-dose will be given at induction and the second half-dose given prior to incision.</description>
          </group>
          <group group_id="O2">
            <title>Fentanyl (Low Dose)</title>
            <description>This arm will receive a total of 10 mcg/kg of Fentanyl (Low Dose). First half-dose will be given at induction and second half -dose given before incision.
Fentanyl (Low Dose): Fentanyl (Low Dose) 10 mcg/kg in two divided doses. Half-dose will be given at induction and the second half-dose given prior to incision.</description>
          </group>
          <group group_id="O3">
            <title>Fentanyl (Low Dose) + Dexmedetomidine</title>
            <description>This arm will receive10 mcg/kg of Fentanyl (Low Dose) -2 divided doses. Dexmedetomidine (Dex) loading dose-1 mcg/kg over 10 min, then Dex infusion at 0.5mcg/kg/hr.
Fentanyl (Low Dose) + Dexmedetomidine: Fentanyl (Low Dose) + Dexmedetomidine. Dexmedetomidine at 1mcg/kg loading dose over 10 minutes, followed by an infusion at a rate of 0.5mcg/kg/hr. In addition, this group will receive a total of 10 mcg/kg Fentanyl (Low Dose). Half the dose will be given at induction and the second half before incision.</description>
          </group>
        </group_list>
        <measure>
          <title>Stress Hormone Levels</title>
          <description>Cortisol, epinephrine, and norepinephrine assayed by enzyme-linked immunosorbent assay (ELISA).</description>
          <units>ng/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="16"/>
                <count group_id="O3" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline Norepinephrine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.32618" spread="10.1541"/>
                    <measurement group_id="O2" value="19.34153" spread="9.880667"/>
                    <measurement group_id="O3" value="19.45968" spread="13.08422"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Sternotomy Norepinephrine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.2606" spread="9.929948"/>
                    <measurement group_id="O2" value="17.08766" spread="8.419782"/>
                    <measurement group_id="O3" value="12.74458" spread="11.4669"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Bypass Norepinephrine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.35796" spread="13.54953"/>
                    <measurement group_id="O2" value="22.31064" spread="17.06955"/>
                    <measurement group_id="O3" value="19.73612" spread="17.07041"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>End-of-Surgery Norepinephrine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.22376" spread="8.599634"/>
                    <measurement group_id="O2" value="10.74731" spread="8.144776"/>
                    <measurement group_id="O3" value="7.727055" spread="13.04373"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hour Post-Surgery Norepinephrine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.03031" spread="17.41692"/>
                    <measurement group_id="O2" value="20.85433" spread="18.38192"/>
                    <measurement group_id="O3" value="26.67379" spread="26.06332"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline ephinephrine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.7848" spread="3.127335"/>
                    <measurement group_id="O2" value="6.439221" spread="7.528216"/>
                    <measurement group_id="O3" value="5.876335" spread="9.551871"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Sternotomy Epinephrine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.376012" spread="2.273879"/>
                    <measurement group_id="O2" value="9.843591" spread="8.670264"/>
                    <measurement group_id="O3" value="10.89824" spread="16.85818"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Bypass Epinephrine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.176" spread="22.04968"/>
                    <measurement group_id="O2" value="21.9075" spread="15.02187"/>
                    <measurement group_id="O3" value="20.5294" spread="17.2838"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>End-of-Surgery Epinephrine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.65742" spread="18.34983"/>
                    <measurement group_id="O2" value="8.620669" spread="6.799042"/>
                    <measurement group_id="O3" value="8.083004" spread="8.808354"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hour Post-Surgery Epinephrine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.004787" spread="6.666509"/>
                    <measurement group_id="O2" value="3.537063" spread="2.466451"/>
                    <measurement group_id="O3" value="4.418208" spread="6.764226"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline Cortisol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="334.7762" spread="314.6592"/>
                    <measurement group_id="O2" value="449.1974" spread="279.4671"/>
                    <measurement group_id="O3" value="352.4913" spread="265.2216"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Sternotomy Cortisol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="353.5396" spread="281.4853"/>
                    <measurement group_id="O2" value="363.5948" spread="164.9006"/>
                    <measurement group_id="O3" value="361.0074" spread="223.3172"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Bypass Cortisol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="279.0063" spread="188.1155"/>
                    <measurement group_id="O2" value="395.1298" spread="173.3926"/>
                    <measurement group_id="O3" value="354.8089" spread="210.7565"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>End-of-Surgery Cortisol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="333.0644" spread="294.8148"/>
                    <measurement group_id="O2" value="463.3857" spread="251.6977"/>
                    <measurement group_id="O3" value="387.3673" spread="191.7376"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hour Post-Surgery Cortisol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="237.5506" spread="243.8181"/>
                    <measurement group_id="O2" value="266.8754" spread="239.2913"/>
                    <measurement group_id="O3" value="265.7373" spread="291.3256"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Stanford-Binet Cognitive Ability</title>
        <description>The Stanford-Binet Intelligence Scale is now in its fifth edition (SB5) and was released in 2003. It is a cognitive ability and intelligence test that is used to diagnose developmental or intellectual deficiencies in young children. The test measures five weighted factors and consists of both verbal and nonverbal subtests. The five factors being tested are knowledge, quantitative reasoning, visual-spatial processing, working memory, and fluid reasoning. Raw scores for each subtest within the overall test are converted to scaled scores using a table within each test manual to look up equivalents. Scaled scores are then converted to standard scores (range=50-150). Higher scores suggest a higher level of functioning related to each category.</description>
        <time_frame>1-4 yrs post-surgery</time_frame>
        <population>Six patients underwent their surgical repair after 1 y of age and were excluded from the follow-up neurodevelopmental testing post-surgery. 2 patients were deceased, 11 families refused to participate, 8 patients could not be reached due to relocation to other states or outside the country leaving a total of 21 patients.</population>
        <group_list>
          <group group_id="O1">
            <title>Fentanyl (High Dose)</title>
            <description>patients in this arm will receive a total of 25 mcg/kg of Fentanyl (High Dose) in two divided doses. first half will be given at induction and the second half will be given before incision.
Fentanyl (High Dose): 25 mcg/kg in two divided doses. half the dose will be given at induction and the second half will be given prior to incision.</description>
          </group>
          <group group_id="O2">
            <title>Fentanyl (Low Dose)</title>
            <description>patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half will be given before incision
Fentanyl (Low Dose): patients will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half before incision.</description>
          </group>
          <group group_id="O3">
            <title>Fentanyl (Low Dose) + Dexmedetomidine</title>
            <description>patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose) in two divided doses and Dexmedetomidine at a loading dose of 1mcg/kg over 10 minutes and then an infusion of Dexmedetomidine at 0.5mcg/kg/hr.
Fentanyl (Low Dose) + Dexmedetomidine: Dexmedetomidine at 1mcg/kg loading dose over 10 minutes, followed by an infusion at a rate of 0.5mcg/kg/hr. In addition, this group will receive a total of 10 mcg/kg Fentanyl (Low Dose). Half the dose will be given at induction and the second half before incision.</description>
          </group>
        </group_list>
        <measure>
          <title>Stanford-Binet Cognitive Ability</title>
          <description>The Stanford-Binet Intelligence Scale is now in its fifth edition (SB5) and was released in 2003. It is a cognitive ability and intelligence test that is used to diagnose developmental or intellectual deficiencies in young children. The test measures five weighted factors and consists of both verbal and nonverbal subtests. The five factors being tested are knowledge, quantitative reasoning, visual-spatial processing, working memory, and fluid reasoning. Raw scores for each subtest within the overall test are converted to scaled scores using a table within each test manual to look up equivalents. Scaled scores are then converted to standard scores (range=50-150). Higher scores suggest a higher level of functioning related to each category.</description>
          <population>Six patients underwent their surgical repair after 1 y of age and were excluded from the follow-up neurodevelopmental testing post-surgery. 2 patients were deceased, 11 families refused to participate, 8 patients could not be reached due to relocation to other states or outside the country leaving a total of 21 patients.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Quantative Reasoning Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="106" spread="22"/>
                    <measurement group_id="O2" value="96" spread="18"/>
                    <measurement group_id="O3" value="82" spread="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Knowledge Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91" spread="27"/>
                    <measurement group_id="O2" value="97" spread="10"/>
                    <measurement group_id="O3" value="95" spread="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visual Spatial Processing Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91" spread="17"/>
                    <measurement group_id="O2" value="97" spread="16"/>
                    <measurement group_id="O3" value="92" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Working Memory Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94" spread="17"/>
                    <measurement group_id="O2" value="92" spread="10"/>
                    <measurement group_id="O3" value="84" spread="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fluid Reasoning Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86" spread="20"/>
                    <measurement group_id="O2" value="93" spread="19"/>
                    <measurement group_id="O3" value="75" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>ABAS-II</title>
        <description>The ABAS-II is designed to evaluate whether an individual displays various functional skills necessary for daily living without the assistance of others. Thus, this instrument focuses on independent behaviors and measures what an individual actually does, in addition to measuring what he or she may be able to do. In addition, the ABAS-II focuses on behaviors an individual displays on his or her own, without assistance from others. The Parent/Primary Caregiver Form is a comprehensive, diagnostic measure of the adaptive skills that have primary relevance for the functioning of infants, toddlers, and preschoolers in the home and other settings, and can be completed by parents or other primary care providers. Each composite or domain score is determined by summing the appropriate scaled scores and then determining its equivalent composite or domain score by looking it up in a table located in the manual.The range for all scores is 50-150, with a higher score equaling a better outcome.</description>
        <time_frame>1-4 yrs post-surgery</time_frame>
        <population>Six patients underwent their surgical repair after 1 y of age and were excluded from the follow-up neurodevelopmental testing post-surgery. 2 patients were deceased, 11 families refused to participate, 8 patients could not be reached due to relocation to other states or outside the country leaving a total of 21 patients.</population>
        <group_list>
          <group group_id="O1">
            <title>Fentanyl (High Dose)</title>
            <description>patients in this arm will receive a total of 25 mcg/kg of Fentanyl (High Dose) in two divided doses. first half will be given at induction and the second half will be given before incision.
Fentanyl (High Dose): 25 mcg/kg in two divided doses. half the dose will be given at induction and the second half will be given prior to incision.</description>
          </group>
          <group group_id="O2">
            <title>Fentanyl (Low Dose)</title>
            <description>patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half will be given before incision
Fentanyl (Low Dose): patients will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half before incision.</description>
          </group>
          <group group_id="O3">
            <title>Fentanyl (Low Dose) + Dexmedetomidine</title>
            <description>patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose) in two divided doses and Dexmedetomidine at a loading dose of 1mcg/kg over 10 minutes and then an infusion of Dexmedetomidine at 0.5mcg/kg/hr.
Fentanyl (Low Dose) + Dexmedetomidine: Dexmedetomidine at 1mcg/kg loading dose over 10 minutes, followed by an infusion at a rate of 0.5mcg/kg/hr.in addition this group will receive a total of 10 mcg/kg Fentanyl (Low Dose). Half the dose will be given at induction and the second half before incision.</description>
          </group>
        </group_list>
        <measure>
          <title>ABAS-II</title>
          <description>The ABAS-II is designed to evaluate whether an individual displays various functional skills necessary for daily living without the assistance of others. Thus, this instrument focuses on independent behaviors and measures what an individual actually does, in addition to measuring what he or she may be able to do. In addition, the ABAS-II focuses on behaviors an individual displays on his or her own, without assistance from others. The Parent/Primary Caregiver Form is a comprehensive, diagnostic measure of the adaptive skills that have primary relevance for the functioning of infants, toddlers, and preschoolers in the home and other settings, and can be completed by parents or other primary care providers. Each composite or domain score is determined by summing the appropriate scaled scores and then determining its equivalent composite or domain score by looking it up in a table located in the manual.The range for all scores is 50-150, with a higher score equaling a better outcome.</description>
          <population>Six patients underwent their surgical repair after 1 y of age and were excluded from the follow-up neurodevelopmental testing post-surgery. 2 patients were deceased, 11 families refused to participate, 8 patients could not be reached due to relocation to other states or outside the country leaving a total of 21 patients.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>ABAS-II General Adaptive Composite Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96" spread="21"/>
                    <measurement group_id="O2" value="102" spread="13"/>
                    <measurement group_id="O3" value="100" spread="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ABAS-II Conceptual Adaptive Domain Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99" spread="21"/>
                    <measurement group_id="O2" value="106" spread="16"/>
                    <measurement group_id="O3" value="99" spread="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ABAS-II Social Adaptive Domain Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="102" spread="24"/>
                    <measurement group_id="O2" value="106" spread="8"/>
                    <measurement group_id="O3" value="105" spread="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ABAS-II Practical Adaptive Domain Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93" spread="15"/>
                    <measurement group_id="O2" value="96" spread="14"/>
                    <measurement group_id="O3" value="95" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data were collected for each patient from start of surgical procedure until hospital discharge (Length of Hospital Stay averaging 5 Days).</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Fentanyl (High Dose)</title>
          <description>patients in this arm will receive a total of 25 mcg/kg of Fentanyl (High Dose) in two divided doses. first half will be given at induction and the second half will be given before incision.
Fentanyl (High Dose): 25 mcg/kg in two divided doses. half the dose will be given at induction and the second half will be given prior to incision.</description>
        </group>
        <group group_id="E2">
          <title>Fentanyl (Low Dose)</title>
          <description>patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half will be given before incision
Fentanyl (Low Dose): patients will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half before incision.</description>
        </group>
        <group group_id="E3">
          <title>Fentanyl (Low Dose) + Dexmedetomidine</title>
          <description>patients in this group will receive a total of 10mcg/kg of fentanyl in two divided doses and Dexmedetomidine at a loading dose of 1mcg/kg over 10 minutes and then an infusion of Dexmedetomidine at 0.5mcg/kg/hr.
Fentanyl (Low Dose) + Dexmedetomidine: Dexmedetomidine at 1mcg/kg loading dose over 10 minutes, followed by an infusion at a rate of 0.5mcg/kg/hr.in addition this group will receive a total of 10 mcg/kg Fentanyl (Low Dose). Half the dose will be given at induction and the second half before incision.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Morbidity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Unblinded</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Small sample size related to: study components conceived after completion of initial stress response study, declined participation, and loss to follow-up. Inability to obtain pre-surgical baseline neurodevelopmental evaluations.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Aymen Naguib, MD</name_or_title>
      <organization>Nationwide Children's Hospital</organization>
      <phone>6147220596</phone>
      <email>Aymen.Naguib@nationwidechildrens.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

